|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003451,
umls-concept:C0031327,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0205314,
umls-concept:C0369335,
umls-concept:C0442027,
umls-concept:C0679622,
umls-concept:C1280500,
umls-concept:C1442466,
umls-concept:C1514669
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-3-26
|
|
pubmed:abstractText |
BILB 1941 is a potent and specific nonnucleoside inhibitor of the hepatitis C virus (HCV) RNA polymerase in vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:BILB 1941 Study Group,
pubmed-author:BeaulieuPierreP,
pubmed-author:BenhamouYvesY,
pubmed-author:CallejaJosé LuisJL,
pubmed-author:DeterdingKatjaK,
pubmed-author:EnríquezJaimeJ,
pubmed-author:ErhardtAndreasA,
pubmed-author:FornsXavierX,
pubmed-author:FuchsMichaelM,
pubmed-author:Garcia-SamaniegoJavierJ,
pubmed-author:KukoljGeorgeG,
pubmed-author:MarquisMartinM,
pubmed-author:NehmizGerhardG,
pubmed-author:PolStanislasS,
pubmed-author:ReiserMarkusM,
pubmed-author:RossSusanneS,
pubmed-author:SpangenbergHans ChristianHC,
pubmed-author:SteffgenJürgenJ,
pubmed-author:SternJerryJ,
pubmed-author:WiegandJohannesJ,
pubmed-author:WuKateK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
23-32
|
|
pubmed:dateRevised |
2009-4-20
|
|
pubmed:meshHeading |
pubmed-meshheading:19320234-Administration, Oral,
pubmed-meshheading:19320234-Adult,
pubmed-meshheading:19320234-Diarrhea,
pubmed-meshheading:19320234-Dose-Response Relationship, Drug,
pubmed-meshheading:19320234-Double-Blind Method,
pubmed-meshheading:19320234-Enzyme Inhibitors,
pubmed-meshheading:19320234-Genotype,
pubmed-meshheading:19320234-Headache,
pubmed-meshheading:19320234-Hepacivirus,
pubmed-meshheading:19320234-Hepatitis C, Chronic,
pubmed-meshheading:19320234-Humans,
pubmed-meshheading:19320234-Male,
pubmed-meshheading:19320234-Middle Aged,
pubmed-meshheading:19320234-RNA, Viral,
pubmed-meshheading:19320234-RNA Replicase,
pubmed-meshheading:19320234-Sequence Analysis, RNA,
pubmed-meshheading:19320234-Time Factors,
pubmed-meshheading:19320234-Viral Load,
pubmed-meshheading:19320234-Viral Nonstructural Proteins
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.
|
|
pubmed:affiliation |
Klinik für Gastroenterologie, Hepatologie and Infektiologie, Universitätsklinik Düsseldorf, Düsseldorf, Germany. erhardt@uni-duesseldorf.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
